🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to assess the efficacy and safety of the combi...
Status
Completed
Location
University of South Alabama, Mitchell Cancer Institute ( Site 0065)
Start Date
2019-05-02
Trial ID
NCT03834506
Treatments Being Tested
This phase II trials studies how well pembrolizumab and vactosertib work af...
Status
Terminated
Location
University of California, San Francisco
Start Date
2019-07-22
Trial ID
NCT03844750
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of pembrol...
Status
Completed
Location
St Joseph Heritage Healthcare-Oncology ( Site 0004)
Start Date
2021-10-07
Trial ID
NCT05008224
The purpose of this study is to observe and evaluate the efficacy and safet...
Status
Unknown
Location
Tianjin Medical University Cancer Institute and Hospital
Start Date
2021-05-01
Trial ID
NCT04863079
Treatments Being Tested
This multi-institutional, phase 2 clinical trial is studying two doses of p...
Status
Completed
Location
Mayo Clinic
Start Date
2017-01
Trial ID
NCT02818920
Treatments Being Tested
The purpose of this study is to determine safety and preliminary efficacy o...
Status
Recruiting
Location
University of California at San Diego Moores Cancer Center
Start Date
2024-04-22
Trial ID
NCT06385080
Treatments Being Tested
This is a phase II, single arm, open-label, interventional trial of pembrol...
Status
Terminated
Location
Istituto Ortopedico Rizzoli
Start Date
2017-05-30
Trial ID
NCT03013127
Treatments Being Tested
This study is a Phase I/II, multicenter, first-in-human, open-label dose-es...
Status
Active Not Recruiting
Location
Sarah Cannon Research Institute at HealthONE
Start Date
2020-07-17
Trial ID
NCT04561362
Treatments Being Tested
This is a phase II, single arm, multi-centre study to assess the efficacy o...
Status
Active Not Recruiting
Location
Charité - Universitätsmedizin Berlin, Campus Virchow Klinikum
Start Date
2022-02-22
Trial ID
NCT04575961
Treatments Being Tested
Background: Acute myeloid leukemia (AML) is a cancer of the white blood ce...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
2016-12-16
Trial ID
NCT02996474
Treatments Being Tested